Epidemiology and molecular genetics of colorectal cancer

Surgical Oncology

Volumn 7, Issue 3-4, 1998, Pages 115-123

  Fahy, Bridget ^a   Bold, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON POLYP; COLORECTAL CANCER; CULTURAL ANTHROPOLOGY; DNA DAMAGE; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; GENE DELETION; HEREDITY; HUMAN; INCIDENCE; INVASIVE CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR GENETICS; MUTATION; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032293488     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(99)00021-3     Document Type: Article

References (74)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 1999. CA Cancer Journal Clin. 49:1999;8-31.
2. Reddy B.S. Role of dietary fiber in colon cancer: an overview. American Journal of Medicine. 106:1999;16S-19S.
3. Potter J.D. Colorectal cancer: molecules and populations. Journal of National Cancer Institute. 91:1999;916-932.
4. Nagao M., Ochiai M., Ushijima T., Watanabe M., Sugimura T., Nakagama H. Genetic determinant and environmental carcinogens. Mutation Research. 402:1998;85-91.
5. Vecchia C.L., Gallus S., Talamini R., Decarli A., Negri E., Franceschi S. Interaction between selected environmental factors and familial propensity for colon cancer. European Journal of Cancer Prevention. 8:1999;147-150.
6. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
7. Sugarbaker J.P., Gunderson L.L., Wittes R.E. Colorectal cancer. DeVita V.T., Hellman S., Rosenberg S.A. Cancer. principles and practices of oncology, 2nd edition:1985;800-803 J.B. Lippincott, Philadelphia.
8. Fearon E.R. Molecular genetics of colorectal cancer. Annals New York Academy of Sciences. 768:1995;101-110.
9. Knudson A.G. Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Research. 45:1985;1437-1443.
10. Cho K.R., Vogelstein B. Genetic alterations in the adenoma - carcinoma sequence. Cancer Supplement. 70:1992;1727-1731.
11. Sasaki M., Okamoto M., Sato C., Sugio K., Soejima J., Iwama T., Ikeuchi T., Tonomura A., Miyaki M., Sasazuki T. Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with nonpolyposis colorectal carcinoma. Cancer Research. 49:1989;4402-4406.
12. Ashton-Rickardt P.G., Dunlop M.G., Nakamura Y., Morris R.G., Purdie C.A., Steel C.M., Evans H.J., Bird C.C., Wyliie A.H. High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene. 4:1989;1169-1174.
13. Delattre P., Olschwang S., Law D.J., Melot T., Remvikos Y., Salmon R.J., Sastre X., Validire P., Feinberg A.P., Thomas G. Multiple genetic alterations distinguish distal from proximal colorectal cancer. Lancet. 2:1989;353-356.
14. Farr C.J., Marshall C.J., Easty D.J., Wright N.A., Powell S.C., Paraskeva C. A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene. 3:1988;673-678.
15. Feig L.A. The many roads that lead to ras. Science. 260:1993;767-768.
16. Forrester K., Almoguera C., Han K., Grizzle W.E., Perucho M. Detectopm of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature. 327:1987;298-303.
17. Bos J.L., Fearon E.R., Hamilton S.R.et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 327:1987;293-297.
18. Barbacid M. ras Genes. Annual Reviews in Biochemistry. 56:1987;779-827.
19. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M.M., Bos J.L. Genetic alterations during colorectal-tumor development. NEJM. 319:1988;525-532.
20. Kennedy E.P., Hamilton S.R. Genetics of colorectal cancer. Semana Surgical Oncolology. 15:1998;126-130.
21. Shibata D., Schaeffer J., Li Z.H., Capella G., Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. Journal of National Cancer Institute. 85:1993;1058-1063.
22. Pretlow T.P., Brasitus T.A., Fulton N.C., Cheyer C., Kaplan E.L. K-ras mutations in putative preneoplastic lesions in human colon. Journal of National Cancer Institute. 85:1993;2004-2007.
23. Plattner R., Anderson M.J., Sato K.Y., Fasching C.L., Der C.J., Stanbridge E.J. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proceedings of the National Academy of Science of the USA. 93:1996;6665-6670.
24. Shirasawa S., Furuse M., Yokoyama N., Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science. 260:1993;85-88.
25. Burns J., Barton C., Wynford-Thomas D., Lemoine N. In vitro transformation of epithelial cells by ras oncogenes. Epithelial Cell Biology. 2:1993;26-43.
26. Aaltonen L.A., Peltomaki P., Leach F.S.et al. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-815.
27. Kinzler K.W., Nilbert M.C., Vogelstein B., Bryan T., Levy D.B., Smith K.J., Preisinger A.C., Hamilton S.R., Hedge P., Markman A., Carlson M., Joslyn G., Groden J., White R., Miki Y., Miyoshi Y., Nishisho I., Nakamura Y. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 251:1991;1366-1369.
28. Leppert M., Dobbs M., Scambler P., O'Connell P., Nakamura Y., Stauffer D., Woodward S., Burt R., Hughes J., Gardner E., Lathrop M., Wasmuth J., Lalouel J.M., White R. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science. 238:1987;1411-1413.
29. Bodmer W.F., Bailey C.J., Bodmer J., Bussey H.J., Ellis A., Gorman P., Lucibello F.C., Murday V.A., Rider S.H., Scambler P., Sheer D., Solomon E., Spurr N.K. Localization for the gene for familial adenomatous polyposis on chromosome 5. Nature. 328:1987;614-619.
30. Herrera L., Kakati S., Pietrzak E., Sandberg A.A. Gardner syndrome in a man with an interstitial deletion of 5q. American Journal of Medical Genetics. 25:1986;473-476.
31. Peltomaki P., Sistonen P., Mecklin J.P., Pylkkanen L., Aaltonen L., Nordling S., Kere J., Jarvinen H., Hamilton S.R., Petersen G.et al. Evidence that the MCC-APC gene region in 5q21 is not the site for susceptibility to hereditary nonpolyposis colorectal carcinoma. Cancer Research. 52:1992;4530-4533.
32. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New English Journal of Medicine. 329:1993;1318-1327.
33. Lane D.P., Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:1979;261-263.
34. Hansen M.F., Cavenee W.K. Genetics of cancer predisposition. Cancer Research. 47:1987;5518-5527.
35. Baker S.J., Preosonger A.C., Jessup J.M., Paraskeva C., Markowitz S., Willson J.K.V., Hamilton S., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Research. 50:1990;7717-7722.
36. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., vanTuinen P., Ledbetter D.H., Barker D.F., Nakamura Y., White R., Vogelstein B. Chromosomal 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-245.
37. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature. 329:1987;219-222.
38. Fearon E.R., Hamilton S.R., Vogelstein B. Clonal analysis of human colorectal tumors. Science. 238:1987;193-197.
39. Garber J.E., Goldstein A.M., Kantor A.F., Dreyfus M.G., Fraumeni J.F., Li F.P. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Research. 51:1991;6594-6607.
40. Baker S.J., Markowitz S., Fearon E.R., Willson J.K.V., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;912-915.
41. Tanaka K., Oshimura M., Kuchi R., Seki M., Hayashi T., Miyaki M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature. 349:1991;340-342.
42. Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W., Ruppert J.M., Hamilton S.R., Preisinger A.C., Thomas G., Kinzler K.W., Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:1990;49-56.
43. Zetter B.R. Adhesion molecules in tumor metastasis. Semana Cancer Biology. 4:1993;219-229.
44. Jen J., Kim H., Piantadosi S., Liu Z.F., Levitt R.C., Sistonen P., Kinzler K.W., Vogelstein B., Hamilton S.R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. New English Journal of Medicine. 331:1994;213-221.
45. Stern H.S., Smith A. Recognition screening and medical management of familial adenomatous polyposis. Semana Colegio Recueil des Surgery. 6:1995;19-24.
46. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., Sargeant L., Krapcho K., Wolff W., Burt R., Hughes J.P., Warrington J., McPherson J., Wasmuth J., Le Paslier D., Abderrahim H., Cohen D., Leppert M., White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 66:1991;589-600.
47. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
48. Smith K.J., Johnson K.A., Bryan T.M., Hill D.E., Markowitz S., Wilson J.K., Paraskeva C., Petersen G.M., Hamilton S.R., Vogelstein B., Kinzler K.W. The APC gene product in normal and tumor cells. Proceedings of the National Academy of Science of the USA. 90:1993;2846-2850.
49. Miyashiro I., Senda T., Matsumine A., Baeg G.H., Kuroda T., Shimano T., Miura S., Noda T., Kobayashi S., Monden M., Toyoshima K., Akiyama T. Subcellular localization of the APC protein. immunoelectron microscopic study of the association of the APC protein with catenin Oncogene. 11:1995;89-96.
50. Morin P.J., Vogelstein B., Kinzler K.W. Apoptosis and APC in colorectal tumorigenesis. Proceedings of the National Academy of Science USA. 93:1996;7950-7954.
51. Peifer M. Regulating cell proliferation. as easy as APC Science. 272:1996;974-975.
52. Seeling J.M., Miller J.R., Gil R., Moon R.T., White R., Virshup D.M. Regulation of B-catenin signaling by the B56 subunit of protein phosphatase 2A. Science. 283:1999;2089-2091.
53. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a B-catenin - Tcf complex in APC-/-colon carcinoma. Science. 275:1997;1780-1787.
54. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L., Mecklin J.-P., Jarvinen H., Powell S.M., Jen J., Hamilton S.R., Petersen G.M., Kinzler K.W., Vogelstein B., de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-815.
55. Lynch H.T., Smyrk T., Lynch J.F. Overview of the natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). International Journal of Cancer. 69:1996;38-43.
56. Mecklin J.P. Frequency of hereditary colorectal carcinoma. Gastroenterology. 93:1987;1021-1025.
57. Aaltonen L.A., Sankila R., Mecklin J.P.et al. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detection and Prevention. 18:1994;57-63.
58. Ponz de Leon M., Sassatelli R., Benatti P., Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6 year experience of a population based on registry. Cancer. 71:1993;3493-3501.
59. Westlake P.J., Bryant H.E., Huchcroft S.A., Sutherland L.R. Frequency of hereditary nonpolyposis colorectal cancer in Southern Alberta. Dig Dis Sci. 36:1991;1441-1447.
60. Lynch H.T., Kimberling W., Albano W.A.et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer. 56:1985;934-938.
61. Loeb L.A. Microsatellite instability. marker of a mutator phenotype in cancer Cancer Research. 54:1994;5059-5063.
62. Lazar V., Grandjouan S., Bognel C.et al. Accumulation of multiple mutations in tumor suppressor genes during colorectal tumorigenesis in HNPCC patients. Human Molecular Genetics. 3:1994;2257-2260.
63. Leach F.R., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki P., Sistonen P., Aaltonen L.A., Nystrom-Lahti M., Guan X.Y., Zhang J., Meltzer P.S., Yu J.W., Kao F.T., Chen D.J.et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 75:1993;1215-1225.
64. Liu B., Parson R.E., Hamilton S.R., Petersen G.M., Lynch H.T., Watson P., Markowitz S., Willson J.K.V., Green J., de la Chapelle A., Kinzler K.W., Vogelstein B. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Research. 54:1994;4590-4594.
65. Fishel R., Lescoe M.K., Rao M.R.S., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027-1038.
66. Han H.J., Maruyama M., Baba S.et al. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Human Molecular Genetics. 4:1995;237-242.
67. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Lindblom A., Tannergard P., Bollag R.J., Godwin A.R., Ward D.C., Nordenskjold M., Fishel R., Kolodner R., Liskay R.M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368:1994;258-261.
68. Nicolaides N.C., Papadopoulos N., Liu B.et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371:1994;75-80.
69. Hecht J.R. Metastasis in colorectal cancer. what makes the tumor aggressive? European Journal of Surgical Supplement. 582:1998;104-110.
70. Radinsky R., Ellis L.M. Molecular determinants in the biology of liver metastasis. Surgical Oncology Clinics of North America. 5:1996;215-229.
71. Fidler I.J., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
72. Bold R.J., Termuhlen P.M., McConkey D.M. Apoptosis, cancer and cancer therapy. Surgical Oncology. 6:1997;133-142.
73. Reed J.C. Regulation of apoptosis by BCL-2 family proteins and its role in cancer and chemoresistance. Current Opinion on Oncolology. 7:1995;541-546.
74. Gil J., Yamamoto H., Zapata J.M., Reed J.C., Perucho M. Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers. Cancer Research. 59:1999;2034-2037.